Staging of breast cancer with PET/CT

Staging of breast cancer with PET/CT

No abstact available.

Bibliographic Details
Main Authors:	J S Moller, W H Pieterse, P D du Toit, S Bonnet, A Diedericks, W Brummer
Format:	Article
Language:	English
Published:	AOSIS 2008-03-01
Series:	South African Journal of Radiology
Subjects:	PET/CT
Online Access:	https://sajr.org.za/index.php/sajr/article/view/561

Similar Items

Response assessment in lymphoma with PET/CT
by: J S Moller, et al.
Published: (2008-03-01)

PET/CT and SPECT/CT Imaging of HER2-Positive Breast Cancer
by: Jeremy McGale, et al.
Published: (2023-07-01)

Progress and Future Trends in PET/CT and PET/MRI Molecular Imaging Approaches for Breast Cancer
by: Yue Ming, et al.
Published: (2020-08-01)

Role of positron-emission tomography/computed tomography (PET/CT) in breast cancer
by: Mohamed Shawky, et al.
Published: (2020-07-01)

Value of contrast CT in combination with PET/CT in mesothelioma staging: Optimal protocol for initial assessment
by: Mohamed Houseni, et al.
Published: (2017-03-01)

PET/CT in initial staging and therapy response assessment of lymphoma
by: Nagham Nabil Omar, et al.
Published: (2016-12-01)

Prone versus Supine FDG PET/CT in the Staging of Breast Cancer
by: Lara Nassar, et al.
Published: (2023-01-01)

Value of integrated PET/CT in detection of hepatic metastatic deposits
by: Susan Adil Ali, et al.
Published: (2016-06-01)

Adapting Imaging Protocols for PET-CT and PET-MRI for Immunotherapy Monitoring
by: Bettina Beuthien-Baumann, et al.
Published: (2021-11-01)

Skeletal metastasis as detected by 18F-FDG PET with negative CT of the PET/CT: Frequency and impact on cancer staging and or management
by: Fatma Ahmed, et al.
Published: (2016-10-01)

An economic evaluation of positron emission tomography (PET) and positron emission tomography/computed tomography (PET/CT) for the diagnosis of breast cancer recurrence
by: P Auguste, et al.
Published: (2011-04-01)

Usefulness of PET–CT in the evaluation of suspected recurrent ovarian carcinoma
by: Mona Abdel Ghaffar ElHariri, et al.
Published: (2019-08-01)

FDG-PET/CT in lymphoma
by: Maria M D′souza, et al.
Published: (2013-01-01)

State of the Art in 2022 PET/CT in Breast Cancer: A Review
by: Jules Zhang-Yin
Published: (2023-01-01)

Characterisation of MRI Indeterminate Breast Lesions Using Dedicated Breast PET and Prone FDG PET-CT in Patients with Breast Cancer—A Proof-of-Concept Study
by: Anmol Malhotra, et al.
Published: (2020-09-01)

Peritoneal deposits: PET/CT the keen observer
by: Nora Nabil Abdou Ahmed Mikawy, et al.
Published: (2023-05-01)

Pretherapeutic Assessment of Pancreatic Cancer: Comparison of FDG PET/CT Plus Delayed PET/MR and Contrast-Enhanced CT/MR
by: Zaizhu Zhang, et al.
Published: (2022-01-01)

PET and PET/CT imaging for the earliest detection and treatment of colorectal carcinoma
by: Kevin Carter, et al.
Published: (2005-10-01)

Clinical usefulness of PET-CT in staging, evaluation of treatment response and restaging of thoracic lymphoma
by: Ahmed Elsammak
Published: (2017-12-01)

PET/CT Radiomics in Lung Cancer: An Overview
by: Francesco Bianconi, et al.
Published: (2020-03-01)

Diagnostic value of integrated 18F-FDG PET/MRI for staging of endometrial carcinoma: comparison with PET/CT
by: Yang Yu, et al.
Published: (2022-09-01)

The role of 18F-FDG-PET/CT in the preoperative staging and posttherapy follow up of gastriccancer:Comparison with spiral CT
by: Soydal Cigdem, et al.
Published: (2011-07-01)

Integrated Small Animal PET/CT/RT with Onboard PET/CT Image Guidance for Preclinical Radiation Oncology Research
by: Xinyi Cheng, et al.
Published: (2023-03-01)

Role of PET/CT in Oropharyngeal Cancers
by: Emily W. Avery, et al.
Published: (2023-05-01)

68Ga PSMA-11 PET with CT urography protocol in the initial staging and biochemical relapse of prostate cancer
by: Amir Iravani, et al.
Published: (2017-12-01)

EANM guidelines for PET-CT and PET-MR routine quality control
by: Michel Koole, et al.
Published: (2023-02-01)

First Live-Experience Session with PET/CT Specimen Imager: A Pilot Analysis in Prostate Cancer and Neuroendocrine Tumor
by: Lorenzo Muraglia, et al.
Published: (2023-02-01)

CT protocol optimisation in PET/CT: a systematic review
by: V. Bertolini, et al.
Published: (2020-03-01)

CT, MRI, and 18F-FDG PET/CT imaging features of seven cases of adult pancreatoblastoma
by: Mengnan Wu, et al.
Published: (2022-12-01)

Up and down staging of TCC using 18F-FDG PET/CT scan
by: Tamer W. Kassem
Published: (2016-09-01)

The Value of <sup>68</sup>Ga-PSMA PET/CT Following Equivocal <sup>18</sup>F-NaF PET/CT in Prostate Cancer Patients
by: Claus Madsen, et al.
Published: (2020-05-01)

The utility of 18F-FDG PET and PET/CT in the diagnosis and staging of chondrosarcoma: a meta-analysis
by: Qingyu Zhang, et al.
Published: (2020-06-01)

A Study on the Application of 18F-FDG-PET-CT for the Radiotherapy of Patients with Stage III Non-small Cell Lung Cancer
by: Shandan, et al.
Published: (2010-07-01)

The elements and specification of 18F-FDG PET-CT and PET-MR tumor imaging report in Shanghai
Published: (2021-01-01)

Image quality and detectability in Siemens Biograph PET/MRI and PET/CT systems—a phantom study
by: Silje Kjærnes Øen, et al.
Published: (2019-08-01)

The Implementation of FDG PET/CT for Staging Bladder Cancer: Changes in the Detection and Characteristics of Occult Nodal Metastases at Upfront Radical Cystectomy?
by: Sarah M. H. Einerhand, et al.
Published: (2023-05-01)

Synchronous Malignancies Identified by PET-CT Scan in Breast Cancer Patients
by: Maya Paran, et al.
Published: (2022-04-01)

Prognostic impact of 18F-FDG PET/CT in pathologic stage II invasive ductal carcinoma of the breast: re-illuminating the value of PET/CT in intermediate-risk breast cancer
by: Hye Lim Park, et al.
Published: (2023-01-01)

The Role of PET-CT in Gastric Cancer — A Narrative Review
by: Raluca-Ioana Dascălu, et al.
Published: (2020-09-01)

Comparison of integrated PET/MRI with PET/CT in evaluation of endometrial cancer: a retrospective analysis of 81 cases
by: Li-hua Bian, et al.
Published: (2019-07-01)